Results 271 to 280 of about 115,437 (312)

Clonal dynamics of tumor-infiltrating lymphocytes

European Journal of Immunology, 2005
The presence of tumor-infiltrating lymphocytes (TIL) provides important evidence of anti-tumor immunity in vivo. However, TIL are usually not sufficient for inhibiting tumor growth. We explored the spatial and temporal aspects of clonal accumulation of TIL using RT-PCR/single-strand conformation polymorphism analysis.
Rong, Yu, Keishi, Fujio, Hiroyuki, Tahara, Yasuto, Araki, Kazuhiko, Yamamoto   +4 more
openaire   +2 more sources

Tumor-Infiltrating Lymphocyte Therapy

The Cancer Journal, 2015
Autologous adoptive T-cell therapies have made tremendous strides over the last few years with excitement currently being generated by technologies that can reprogram T-cell specificities toward any desired antigen including chimeric antigen receptors and recombinant T-cell receptors.
openaire   +2 more sources

Reporting Tumor Infiltrating Lymphocytes

2012
The presence of many tumor infiltrating lymphocytes (TILs) in primary cutaneous melanoma is associated with a better prognosis. The degree of lymphocytic interaction with the tumor cells is graded as “brisk”, “non-brisk” or “absent” as defined below:
Kasia Szyfelbein Masterpol, Andrea Primiani, Lyn McDivitt Duncan   +2 more
openaire   +1 more source

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival

Melanoma Research, 2015
Understanding differences in survival across distinct subgroups of melanoma patients may help with the choice of types of therapy. Tumor-infiltrating lymphocytes (TILs) are considered a manifestation of the host immune response to tumor, but the role of TILs in melanoma mortality is controversial.
Cristina, Fortes, Simona, Mastroeni, Thomas J, Mannooranparampil, Francesca, Passarelli, Alba, Zappalà, Giorgio, Annessi, Claudia, Marino, Alessio, Caggiati, Nicoletta, Russo, Paola, Michelozzi   +9 more
openaire   +2 more sources

Tumor-infiltrating lymphocytes: A new hope

Cancer Cell
Tumor-infiltrating lymphocytes (TILs) can be massively expanded from resected tumors and used as a cellular treatment for advanced malignancies. TILs require a preparative non-myeloablative chemotherapy followed by an abbreviated course of interleukin-2.
Amod A, Sarnaik, Patrick, Hwu, James J, Mulé, Shari, Pilon-Thomas   +3 more
openaire   +2 more sources

Tumor-Infiltrating Lymphocyte Therapy and Neoantigens

The Cancer Journal, 2017
The adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes has been shown to be effective at mediating tumor regression in more than half of patients with metastatic melanoma and in mediating long-term complete regression in approximately one fourth of all patients with this cancer.
openaire   +2 more sources

TUMOR INFILTRATING LYMPHOCYTES*

Annals of the New York Academy of Sciences, 1976
E, Klein, S, Becker, E, Svedmyr, M, Jondal, F, Vánky   +4 more
openaire   +2 more sources

Tumor-Infiltrating Lymphocytes

Acta Cytologica, 1996
Gary Oliver, John Yannelli, Diane Solomon   +2 more
openaire   +1 more source

Tumor-infiltrating lymphocytes

Critical Reviews in Oncology/Hematology, 1992
Theresa L. Whiteside, Lorenz M. Jost, Ronald B. Herberman   +2 more
openaire   +1 more source

Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma

New England Journal of Medicine, 2023
Maartje W, Rohaan, Rob, Kessels, John B A G, Haanen   +2 more
openaire   +3 more sources